Theravance Biopharma Inc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TBPH research report →
About the company
Theravance Biopharma, Inc. , a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA).
- CEO
- Rick E. Winningham
- IPO
- 2014
- Employees
- 90
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $877.45M
- P/E
- 7.48
- P/S
- 7.99
- P/B
- 2.99
- EV/EBITDA
- 4.65
- Div Yield
- 0.00%
- Gross Margin
- 80.37%
- Op Margin
- 0.08%
- Net Margin
- 104.34%
- ROE
- 43.85%
- ROIC
- 0.02%
- Revenue
- $107.46M · 66.92%
- Net Income
- $105.89M · 287.70%
- EPS
- $2.10 · 282.61%
- Op Income
- $-13,246,000
- FCF YoY
- 2109.77%
- 52W High
- $21.03
- 52W Low
- $10.82
- 50D MA
- $16.59
- 200D MA
- $16.78
- Beta
- 0.17
- Avg Volume
- 518.02K
Get TickerSpark's AI analysis on TBPH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 19, 26 | Miller Aine | other | 18,750 |
| Jun 15, 26 | Farnum Rhonda | sell | 3,329 |
| Jun 15, 26 | Farnum Rhonda | sell | 3,328 |
| Jun 15, 26 | Farnum Rhonda | sell | 6,657 |
| Jun 12, 26 | Smaldone Alsup Laurie | other | 6,009 |
| Jun 12, 26 | Smaldone Alsup Laurie | other | 13,398 |
| Jun 12, 26 | GRAY SUSANNAH | other | 6,009 |
| Jun 12, 26 | GRAY SUSANNAH | other | 13,398 |
| Jun 12, 26 | MITCHELL DEAN J | other | 6,009 |
| Jun 12, 26 | MITCHELL DEAN J | other | 13,398 |
Our TBPH coverage
Recent articles, reports, and earnings notes.
No research on TBPH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TBPH report →Similar companies
Peers in the same neighborhood.